Brand Name | Cimzia |
Generic Name | Certolizumab Pegol |
Drug Class | Tumor Necrosis Factor (TNF) Blocker |
Availability | Prescription |
Manufacturer | UCB Pharma |
Indications | Rheumatoid arthritis, Crohn's disease, Psoriatic arthritis |
Type | Injection |
Doses | 200-400 mg every 2-4 weeks |
Route | Subcutaneous |
Side Effects | Injection site reactions, fatigue, infections |
Interactions | Biologics, immunosuppressants |
Overdose | Seek emergency help for serious infections |
Missed Dose | Administer as soon as possible, do not double dose |
Contraindications | Active infections, tuberculosis |
Alternatives | Humira, Enbrel |
Co-Pay Assistance Program | Available |
Patient Assistance Program | Available |
Certolizumab Pegol is used to treat autoimmune diseases such as Crohn's disease, rheumatoid arthritis, and psoriatic arthritis by suppressing the immune system.
Certolizumab Pegol works by binding to TNF-alpha, a protein involved in inflammation, and blocking its action to reduce inflammation and symptoms.
Common side effects include headache, upper respiratory infections, and nausea.
Yes, Certolizumab Pegol can be taken with or without food.
Certolizumab Pegol should be used during pregnancy only if absolutely necessary. Consult your doctor before using it during pregnancy.
If you miss a dose, contact your healthcare provider to reschedule your next dose.
Certolizumab Pegol can take several weeks to show noticeable improvement in symptoms.
Certolizumab Pegol can be used long-term for chronic conditions, but regular monitoring by your healthcare provider is important to assess effectiveness and side effects.
Yes, Certolizumab Pegol can interact with other immunosuppressive medications, including other TNF inhibitors. Inform your doctor about all medications you're taking.
If you experience severe side effects, such as difficulty breathing, signs of infection, or swelling, contact your doctor immediately.
Related Conditions |
Related Blogs |
---|---|